SELLAS Life Sciences
SLS
SLS
26 hedge funds and large institutions have $11.3M invested in SELLAS Life Sciences in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 27 → 26 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
26
Holding in Top 10
–
Calls
$1.98M
Puts
$1.05M
Top Buyers
| 1 | +$208K | |
| 2 | +$91.9K | |
| 3 | +$54K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.7K |
| 5 |
D.E. Shaw & Co
New York
|
+$19.7K |
Top Sellers
| 1 | -$219K | |
| 2 | -$183K | |
| 3 | -$77K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$71.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$67.9K |